Neogenix gets FDA nod to start Phase I study of pancreatic and ... - Therapeutics Daily (press release) (registration)

Neogenix gets FDA nod to start Phase I study of pancreatic and ...Therapeutics Daily (press release) (registration)Anti-tumour activity has been demonstrated in both in-vitro ADCC assays and in multiple animal studies. NPC-1C is derived from a colorectal cancer vaccine ...Pancreatic and Colorectal Cancer Novel Antibody Developed from a ...MarketWatch (press release)all 11 news articles »